Name: ONCY Balance Sheet - Oncolytics Biotech Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ONCY - Oncolytics Biotech Inc.

USD | NASDAQ | Healthcare

ONCY Balance Sheet - Oncolytics Biotech Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	5.2	11.1	-
Restricted Cash	-	-	-
Short Term Investments	-	-	-
Cash And Short Term Investments	5.2	11.1	-
Receivables
Accounts Receivable	-	-	-
Current Assets
Inventory	-	-	-
Prepaid Expenses	1.1	1.3	-
Other Current Assets	-	-	-
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	0.8	0.7	-
Accumulated Depreciation	0.5	0.4	-
Property,Plant & Equipment Net	0.2	0.3	-
Long Term Investments
Current Liabilities
Accounts Payable	3.5	0.8	-
Short Term Debt	-	-	-
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	-	-	-
Operating Lease Liabilities Non-Current	0.4	0.6	-
Deferred Revenue Non-Current	4.9	4.7	5.1
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	-
Additional Paid In Capital	419.5	397.7	-
Retained Earnings	(429.5)	(400.7)	-
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	-	-	-
Net debt	-	-	-
Working Capital	0.7	7.6	-
Book Value	(3.8)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q1 FY 25	Q4 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	5.5	5.2	-	-	-
Restricted Cash	-	-	-	-	-
Short Term Investments	-	-	-	-	-
Cash And Short Term Investments	5.5	5.2	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	1.0	1.1	-	-	-
Other Current Assets	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Property,Plant & Equipment Net	0.2
Current Liabilities
Accounts Payable	2.7	3.5	-	-	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.3	0.4	-	-	-
Deferred Revenue Non-Current	4.9
Common Equity
Common Stock	0.0	0.0	-	-	-
Additional Paid In Capital	427.4	419.5	-	-	-
Retained Earnings	(438.7)	(429.5)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	2.1	0.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)